What a great post BIT, thanks for posting that!! I initially got into BNC because of Econiche a couple years back and then started to learn about MCC and obviously MCC is the one thing that not only can change the company incredibley but could have great worldwide implications on healing. WHen you look at the below chart from BNC's website its unbelievable to think what this company might look like in 10 years, assuming Urocidin gets approved. But as you say with current management they'll be lucky to finish bladder cancer trials if they dont wake up!! They need a partner, there is no other way. I can understand the delay in negotiations that is for sure, as BNC probably knows exactly what they have in MCC and do not want to give it away at a fire sale. Perhaps big pharma knows as well and they are trying to get rights to a lot more than Urocidin.